NCT01904357View on ClinicalTrials.gov

Pediatric Cefazolin PK Study

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

September 30, 2013

Conditions
Infections
Interventions
DRUG

Cefazolin 1 GM Injection

Subjects weighing ≥25 kg and \< 50 kg will receive the 1g dose.

DRUG

Cefazolin 2 GM Injection

Subjects weighing ≥50 kg to ≤85 kg will receive the 2g dose.

Trial Locations (2)

43606

Toledo Children's Hospital, Toledo

72205

Arkansas Children's Hospital, Little Rock

All Listed Sponsors
lead

B. Braun Medical Inc.

INDUSTRY

NCT01904357 - Pediatric Cefazolin PK Study | Biotech Hunter | Biotech Hunter